BioCentury
ARTICLE | Clinical News

Cyclosporine: Began pharmacokinetic studies of formulations in healthy volunteers, which will be compared to Sandoz's Sandimmune formulation of the drug. SANG e

October 23, 1995 7:00 AM UTC

SangStat Medical Corp. (SANG), Menlo Park, Calif. Product: Cyclosporine Indication: Prevent organ transplant rejection Status: Began pharmacokinetic studies of formulations in healthy volunteers, whic...